In This Section      
 

Pharmacy Residency Program: Oncology

General Information

Program Type: ASHP-Accredited PGY2 Oncology 
ASHP Match Number: 537860

Purpose Statement:

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The Cancer Center

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is one of approximately 40 cancer centers in the United States designated by the National Cancer Institute (NCI) as a comprehensive cancer center. Adult oncology patients seen at the Cancer Center receive care primarily in the Weinberg Building and Viragh Outpatient Building in East Baltimore. An oncology pharmacy satellite within the Weinberg building provides pharmaceutical care for over 80 inpatient oncology beds dedicated to Medical Oncology, Hematology and Bone Marrow Transplantation services, an outpatient oncology clinic where over 120 doses of chemotherapy are administered each day, and an oncology investigational drug service that supports approximately 350 active oncology clinical trials. Cancer Center services are also provided at Johns Hopkins Bayview Medical Center and Green Spring Station.

Currently, sixteen clinical pharmacy specialists provide clinical services to patients seen at our Cancer Center, including six in the inpatient setting, six in ambulatory oncology clinics, two in pain and palliative care, and one each in pediatric oncology, clinical decision support, and surgical oncology. The residents also interact with numerous clinical pharmacy generalists and oncology pharmacy administrators in the oncology pharmacy satellite. The oncology pharmacy staff participates in therapeutic drug monitoring, provision of drug information, nutrition support, educational in-services, continuing education and patient education.

The Residency

The Johns Hopkins Department of Pharmacy has been involved with residency training since the 1940s. Currently, over 30 residents are completing their training at Johns Hopkins. The ASHP-accredited PGY2 oncology residency began in 2000 and now recruits three residents each year. This 12-month residency provides extensive opportunities for experiential training in both inpatient and ambulatory cancer care. 

In addition to daily clinical patient-care activities, the resident will also have the opportunity to attend multidisciplinary meetings such as oncology grand rounds, disease-specific meetings and case conferences, morbidity and mortality conferences, cancer pain service case conference, as well as pharmacy-supported educational sessions. Residents will complete a medication use evaluation over the course of the year, an ACPE-accredited Pharmacotherapy Rounds presentation, a lecture at the University of Maryland School of Pharmacy, and will write an article for our departmental newsletter. Graduates of this program will gain real-world problem solving and clinical decision support experience, preparing them to practice independently in a variety of inpatient or ambulatory oncology patient-care settings and to successfully obtain BCOP certification.

Rotations: Ten months are devoted to orientation and core experiences; two months are available for electives. Residents will also participate longitudinally in an oncology anticoagulation clinic, oncology clinical decision support, and oncology pharmacy administration. 
 

two medical professionals speaking with a patient in a hospital bed

Core Experiences:

  • Inpatient Medical Oncology
  • Inpatient Hematologic Malignancies  
  • Inpatient Myeloma, Lymphoma and Bone Marrow Transplant
  • Ambulatory oncology clinics including Hematologic Malignancies, Multiple Myeloma, Breast, Melanoma, Thoracic, Gastrointestinal, Genitourinary, and Central Nervous System Malignancies  
  • Pain and Palliative Care
  • Longitudinal Oncology Practice Administration 
  • Longitudinal Investigational Drug Service 
  • Longitudinal Oncology Clinical Decision Support 
  • Longitudinal Oncology Anticoagulation Clinic

Additional Opportunities:

  • Immunocompromised Infectious Disease
  • Pediatric Oncology 
  • Benign Hermatology
  • Gynecologic Oncology

Benefits: Click Here
Staffing: Click Here
On-Call: Click Here
Application Information: 
All applications will be accepted through PHORCAS: Click Here


Program Director

Matthew J. Newman, PharmD, BCOP

Title: Clinical Pharmacist Practitoner, Hernatologic Malignancies
Education: Doctor of Pharmacy, Northeastern University
Training: Pharmacy Practice Residency - The Johns Hopkins Hospital Oncology Specialty
Residency - The Johns Hopkins Hospital

Dr. Newman is a clinical pharmacist practitioner with the inpatient hematologic malignancies service at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital. He is also the Director of the PGY-2 Oncology Residency Program at Johns Hopkins and serves as Clinical Assistant Professor at the University of Maryland School of Pharmacy.

Dr. Newman has published and presented on topics in oncology pharmacy. He is an active member of the Hematology Oncology Pharmacy Association and serves as a peer reviewer for relevant journals.

 

Contact

Matthew J. Newman, PharmD, BCOP
Clinical Pharmacist Practitioner, Hematologic Malignancies
Director, PGY2 Oncology Residency
The Johns Hopkins Hospital
Location: The Johns Hopkins Hospital
600 North Wolfe Street/Carnegie 180
Baltimore, MD 21287
Phone: 410-614-9806
Email: mnewma17@jhmi.edu